<DOC>
	<DOCNO>NCT00995150</DOCNO>
	<brief_summary>The primary objective study assess efficacy levonorgestrel-releasing intrauterine system ( LNG20 ) nulliparous parous female child-bearing potential request long-term , reversible contraception 8 year .</brief_summary>
	<brief_title>A Study Levonorgestrel-Releasing Intrauterine System Long-Term , Reversible Contraception</brief_title>
	<detailed_description>This Phase 3 , randomize , open-label , multicenter evaluation efficacy levonorgestrel-releasing intrauterine system ( LNG20 ) . The goal study include provision information understand efficacy safety within wide range possible user LNG20 . Typically , intrauterine contraceptive study include woman 18-35 year age efficacy safety , place limit parity large body size . Women outside characteristic also desire effective intrauterine contraceptive . Accordingly , study include woman nulliparous parous well woman less 18 year age primary efficacy safety analysis</detailed_description>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Healthy woman request contraception 1635 year old Cohort 3645 year old Sexually active Currently pregnant , pregnant within 4 week prior study entry planning pregnancy within 24 month study entry Currently breastfeed Current persistent , abnormal vaginal bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>contraception</keyword>
	<keyword>intrauterine</keyword>
	<keyword>long-term</keyword>
	<keyword>reversible</keyword>
</DOC>